Article Text

Download PDFPDF
CASE REPORT
Implantable cardiac defibrillator infections: the emerging importance of Mycobacterium fortuitum
  1. Menfil Orellana-Barrios1,
  2. David A Sotello Aviles2,
  3. Olusegun Oyenuga1,
  4. Kenneth Nugent3
  1. 1Department of Cardiology, TTUHSC, Lubbock, Texas, USA
  2. 2Department of Infectious Diseases, Mayo Clinic, Jacksonville, Florida, USA
  3. 3Department t of Internal Medicine Critical Care, TTUHSC, Lubbock, Texas, USA
  1. Correspondence to Dr Menfil Orellana-Barrios, menfil{at}gmail.com

Summary

Infection is a clinically relevant complication associated with intracardiac devices. Atypical mycobacteria, particularly Mycobacterium fortuitum, have been increasingly implicated in cardiovascular implantable electronic device (CIED) infections. We present a case of M. fortuitum CIED infection in a patient with ischaemic cardiomyopathy occurring approximately 3 weeks after insertion. The recognition and adequate treatment, including device removal, tissue sampling and the determination of antimicrobial sensitivities, are essential in the proper management of these patients.

  • Cardiovascular Medicine
  • Pacing And Electrophysiology
  • Infectious Diseases

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Footnotes

  • Contributors MO-B and KN: wrote initial draft. DASA: reviewed the initial draft, OO and KN: proofread the initial draft. MO-B and DASA: performed literature review and summary. MO-B and OO: were directly involved in clinical case. All authors: participated in manuscript design, review and analysis of data; reviewed and approved final version; agreed to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.

  • Competing interests None declared.

  • Patient consent Obtained.

  • Provenance and peer review Not commissioned; externally peer reviewed.